Sign In
Buy XRAY
$9.88
+0.240 (+2.49%)
At Close: Jun 04, 2026
What 8 Analyst Ratings Have To Say About Dentsply Sirona
04:01pm, Thursday, 02'nd Jun 2022 Benzinga
Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
2
5
0
0
Last
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022
02:08pm, Thursday, 02'nd Jun 2022 Benzinga
Upgrades
According to Oppenheimer, the prior rating for SolarEdge Technologies Inc (NASDAQ:SEDG) was changed from Perform to Outperform. For the first quarter, SolarEdge Technologies had an EPS of $1
Dentsply Sirona Declares Quarterly Cash Dividend
12:00pm, Friday, 27'th May 2022 GlobeNewswire Inc.
CHARLOTTE, N.C., May 27, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors declared a quarterly cash dividend of $0.125 pe
Dentsply Stock is Repricing Itself
06:05am, Thursday, 26'th May 2022
Global dental products provider Dentsply (NASDAQ: XRAY) stock has been plunging worse than the benchmark indices down (-34%) on the year.
Moderna Just Made a $700,000 Mistake
12:38pm, Wednesday, 18'th May 2022 The Motley Fool
But it's not the stock that investors should be worried about.
Dentsply Sirona gets Nasdaq listing notice over late 10-Q that was caused by internal probe of financial reporting
08:14am, Wednesday, 18'th May 2022
Dentsply Sirona Inc. XRAY, +1.86% said Wednesday it has received a written notification from the Nasdaq exchange warning that it is no longer in compliance with listing rules because it has not yet fi
Moderna CFO out after two days in the role as former employer Dentsply discloses probe of financial reporting
11:19am, Thursday, 12'th May 2022 MarketWatch
Moderna Inc. surprised investors Wednesday with the news that its recently appointed chief financial officer has departed with immediate effect, following the disclosure of an internal probe into fina
Why Moderna Stock Swooned Today
09:38pm, Wednesday, 11'th May 2022 The Motley Fool
There's some trouble in the C-suite.
What 10 Analyst Ratings Have To Say About Dentsply Sirona
02:06pm, Wednesday, 11'th May 2022 Benzinga
Analysts have provided the following ratings for Dentsply Sirona (NASDAQ:XRAY) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
4
6
0
0
Dentsply Sirona (XRAY) Q1 2022 Earnings Call Transcript
08:30am, Wednesday, 11'th May 2022 The Motley Fool
XRAY earnings call for the period ending March 31, 2022.
Markets Finish Mixed Following Brutal 3-Day Losing Streak
08:06pm, Tuesday, 10'th May 2022 Benzinga
U.S. indices finished Tuesday’s trading session mixed. Markets have been volatile after the Federal Reserve last Wednesday announced it would raise the key interest rate by 50 basis points. A recent
Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance
03:36pm, Tuesday, 10'th May 2022
Dentsply Sirona Inc's (NASDAQ: XRAY) Q1 FY22 sales decreased 6.1% Y/Y to $965 million, missing the consensus of $988.43 billion. Adjusted EPS decreased to $0.52 from $0.72 a year ago and missed the
DENTSPLY SIRONA Inc. (XRAY) Q1 2022 Results - Earnings Call Transcript
02:43pm, Tuesday, 10'th May 2022
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Andrea Daley - VP, IR John Groetelaars - Interim CEO Barbara Bodem - CFO Conference Ca
DENTSPLY SIRONA (XRAY) Reports Weak Q1 Preliminary Results
02:14pm, Tuesday, 10'th May 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) preliminary first-quarter 2022 results reflect weakness in segments.
